Serum sRAGE levels increase in patients with decreased renal function [14,16], and an inverse link between sRAGE and plaque burden in CKD have been reported [17] implicating the RAGE pathway in vascular damage in patients with decreased renal function. The gene discussed is AGER; the disease is chronic kidney disease.